
BTK与B细胞恶性肿瘤的靶向治疗 - 知乎 - 知乎专栏
布鲁顿酪氨酸激酶(Bruton’s tyrosine kinase,BTK)是胞浆内非受体型酪氨酸激酶TEC家族中的一员,在B细胞生长发育、增殖分化过程中起着重要作用,同时也是B细胞恶性肿瘤的治疗靶点。
The role of Bruton's tyrosine kinase in the immune system and …
Bruton's tyrosine kinase (BTK) is a TEC kinase with a multifaceted role in B-cell biology and function, highlighted by its position as a critical component of the B-cell receptor signalling …
Bruton's tyrosine kinase - Wikipedia
Bruton's tyrosine kinase (abbreviated Btk or BTK), also known as tyrosine-protein kinase BTK, is a tyrosine kinase that is encoded by the BTK gene in humans. BTK plays a crucial role in B …
Role of Bruton’s tyrosine kinase in B cells and malignancies
2018年2月19日 · In this review, we discuss the role of BTK in B cell differentiation and B cell malignancies and highlight the importance of BTK inhibition in cancer therapy. Bruton’s …
Targeting Bruton's tyrosine kinase in B cell malignancies
2014年3月24日 · Bruton's tyrosine kinase (BTK) is a key component of B cell receptor (BCR) signalling and functions as an important regulator of cell proliferation and cell...
布鲁顿酪氨酸激酶(Bruton’s tyrosine kinase,BTK)在B细胞和恶 …
2024年2月22日 · Bruton酪氨酸激酶(BTK)是一种非受体激酶,在许多B细胞恶性肿瘤中扮演关键的致癌信号传导作用,对白血病细胞的增殖和存活至关重要。 BTK最初在 X连锁遗传无球蛋白 …
Role of Bruton's tyrosine kinase in B cells and malignancies
2018年2月19日 · Bruton's tyrosine kinase (BTK) is a non-receptor kinase that plays a crucial role in oncogenic signaling that is critical for proliferation and survival of leukemic cells in many B …
Navigating the changing landscape of BTK-targeted therapies for B …
2024年11月1日 · Bruton tyrosine kinase (BTK) is a key node mediating signal transduction downstream of the BCR. The advent of BTK inhibitors has revolutionized the treatment …
5款BTK抑制剂:匹妥布替尼、阿卡替尼、奥布替尼、泽布替尼、伊 …
BTK,即 布鲁顿酪氨酸激酶,是一种非受体酪氨酸激酶,在B淋巴细胞的发育和激活中发挥重要作用。 BTK抑制剂通过抑制BTK的活性来控制肿瘤的生长和转移。 目前市场上有多种BTK抑制 …
Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies: Their Use …
Bruton tyrosine kinase (BTK) is a key signalling molecule in the B-cell receptor pathway which is important for B-cell proliferation and survival. The development of drugs which inhibit BTK has …